Notice to readers: Newly licensed smallpox vaccine to replace old smallpox vaccine
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

current


Notice to readers: Newly licensed smallpox vaccine to replace old smallpox vaccine

  • Published Date:

    February 29, 2008

  • Language:
    English
Filetype[HTM]


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    CDC has begun distribution of a new-generation smallpox vaccine, ACAM2000 (Acambis, Inc., Cambridge, Massachusetts), to civilian laboratory personnel, the military, and state public health preparedness programs. ACAM2000 is a live, vaccinia virus smallpox vaccine that was licensed for use in the United States by the Food and Drug Administration in August 2007 (1).* ACAM2000 will be replacing Dryvax smallpox vaccine (Wyeth Pharmaceuticals, Inc., Marietta, Pennsylvania) because of withdrawal of the Dryvax license. ACAM2000 is a live vaccinia virus derived from plaque purification cloning from Dryvax. The safety data available from the ACAM2000 clinical trials indicate a similar safety profile to Dryvax.
  • Subject:
  • Document Type:
    Journal Issue
  • Place as Subject:
    United States
  • Collection(s):
    Guidelines and Recommendations
  • Main Document Checksum:
  • File Type:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 152.20 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    June 1, 2003
    Series:
    Smallpox
    Description:
    CDC has developed this policy on unused smallpox vaccine in response to questions raised by several smallpox vaccination programs and to provide a rec...
    File Type:
    Filetype[PDF - 152.20 KB]
    File Type:
    Filetype[PDF - 152.20 KB]
  2. Filetype[PDF - 97.42 KB]
    Personal Author:
    Harrison, Lee H.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Smallpox Vaccine Workgroup.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
    Published Date:
    February 27, 2014
    Source:
    07-Flu-Walter.pdf
    Series:
    ACIP meeting Smallpox
    File Type:
    Filetype[PDF - 97.42 KB]
    File Type:
    Filetype[PDF - 97.42 KB]
  3. Filetype[PDF - 3.13 MB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    2/03
    Description:
    Because routine smallpox vaccination ceased 30 years ago, many clinicians are unacquainted with the vaccinia (smallpox) vaccine.This pocket guide prov...
    File Type:
    Filetype[PDF - 3.13 MB]
    File Type:
    Filetype[PDF - 3.13 MB]
  4. Filetype[PDF - 185.13 KB]
    Personal Author:
    Harrison, Lee H.
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Smallpox Vaccine Workgroup.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2015 June 24-25 : Atlanta, GA)
    Published Date:
    June 24, 2015
    Series:
    ACIP meeting Smallpox
    File Type:
    Filetype[PDF - 185.13 KB]
    File Type:
    Filetype[PDF - 185.13 KB]
  5. Filetype[PDF - 106.94 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    March 31, 2003
    Series:
    Smallpox fact sheet
    Description:
    The smallpox vaccine helps the body develop immunity to smallpox. The vaccine is made from a virus called vaccinia which is a “pox”-type virus rel...
    File Type:
    Filetype[PDF - 106.94 KB]
    File Type:
    Filetype[PDF - 106.94 KB]